Dr.Reddy's Laboratories Ltd (REDY.BO)
23 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|50||2014||Chairman of the Board|
|57||2014||Co-Chairman of the Board, Chief Executive Officer, Managing Director|
|56||2012||President, Chief Financial Officer, Global Head - HR and IT & BPE|
|60||2013||President, Global Head - Human Resources|
|49||2018||Chief Operating Officer and Global Head of Generics & PSAI|
- Indian shares close slightly higher; SBI, Dr.Reddy's gain on Q4 results
- UPDATE 1-India's Dr. Reddy's Q4 profit falls 19 pct on U.S. headwinds
- CORRECTED-India's Dr. Reddy's Q4 profit falls about 19 pct, misses estimates
- BRIEF-Dr.Reddy's Labs Gets EIR From USFDA For API Mirfield Plant, UK
- BRIEF-Dr.Reddy's Laboratories Gets EIR From US FDA For API Cuernavaca Plant In Mexico